• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION AUTOGEN; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION AUTOGEN; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D Back to Search Results
Model Number G177
Device Problems Device Sensing Problem (2917); Material Integrity Problem (2978)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 01/27/2019
Event Type  Injury  
Manufacturer Narrative
The explanted device was received and is undergoing laboratory analysis.This report will be updated when analysis is complete.
 
Event Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) and associated non-boston scientific right ventricular (rv) lead exhibited noise during inspiration/expiration on the rate/sense channel.However, this noise was not being sensed by the device.Additional troubleshooting was performed the following month, and the minute ventilation (mv) sensor was programmed off to see if this was the cause of the noise.The same noise remained, and noise was created with certain arm movements.Device data was submitted to technical services for review.No episodes were stored showing the noise, so additional testing was recommended to run egms during testing so the morphology of the noise could be evaluated by technical services.The pacing impedance trends of the lead did not show any suspicious values, indicating the lead conductor is likely not impaired.X-rays could be considered to evaluate the connection between the terminal pin and device header.In april the field representative reported that the competitor's rv lead was explanted and replaced with a non-boston scientific df-4 model and the current device was therefore replaced with a df-4 header device.The physician questioned whether the device header was the source of the noise so the explanted device was returned for laboratory analysis.No adverse patient effects were reported.
 
Manufacturer Narrative
The explanted device was received and is undergoing laboratory analysis.This report will be updated when analysis is complete.Upon receipt at our post market quality assurance laboratory, a thorough evaluation of the device was performed.A visual inspection of the device header and case noted no anomalies.The seal plugs were intact and the setscrews moved freely.Pin gauge testing, designed to verify proper port dimensions, was completed.Each port measured as expected.The device was then exposed to simulated heart load conditions, and the defibrillation, pacing, and sensing functions were tested.Impedance testing was completed and all measurements were within normal limits.The device operated appropriately with no interruptions in therapy output at the returned programmed settings.A series of electrical tests was also performed, and again, normal device function was observed.Analysis did not identify any device characteristics that would have caused or contributed to the reported noise on the rv channel.
 
Event Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) and associated non-boston scientific right ventricular (rv) lead exhibited noise during inspiration/expiration on the rate/sense channel.However, this noise was not being sensed by the device.Additional troubleshooting was performed the following month, and the minute ventilation (mv) sensor was programmed off to see if this was the cause of the noise.The same noise remained, and noise was created with certain arm movements.Device data was submitted to technical services for review.No episodes were stored showing the noise, so additional testing was recommended to run egms during testing so the morphology of the noise could be evaluated by technical services.The pacing impedance trends of the lead did not show any suspicious values, indicating the lead conductor is likely not impaired.X-rays could be considered to evaluate the connection between the terminal pin and device header.In april the field representative reported that the competitor's rv lead was explanted and replaced with a non-boston scientific df-4 model and the current device was therefore replaced with a df-4 header device.The physician questioned whether the device header was the source of the noise so the explanted device was returned for laboratory analysis.No adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AUTOGEN
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
MDR Report Key8870220
MDR Text Key153561086
Report Number2124215-2019-16902
Device Sequence Number1
Product Code NIK
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 10/28/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date04/05/2016
Device Model NumberG177
Device Catalogue NumberG177
Device Lot Number102485
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/17/2019
Initial Date Manufacturer Received 04/23/2019
Initial Date FDA Received08/07/2019
Supplement Dates Manufacturer Received08/22/2019
Supplement Dates FDA Received10/28/2019
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age66 YR
-
-